nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Abnormal pigmentation—Temozolomide—malignant glioma	0.0684	0.18	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Temozolomide—malignant glioma	0.0193	0.0508	CcSEcCtD
Hydroxychloroquine—Visual acuity reduced—Temozolomide—malignant glioma	0.0108	0.0285	CcSEcCtD
Hydroxychloroquine—Hypokinesia—Carmustine—malignant glioma	0.00988	0.026	CcSEcCtD
Hydroxychloroquine—Myopathy—Temozolomide—malignant glioma	0.00919	0.0242	CcSEcCtD
Hydroxychloroquine—Scotoma—Carmustine—malignant glioma	0.00879	0.0231	CcSEcCtD
Hydroxychloroquine—Scotoma—Temozolomide—malignant glioma	0.00849	0.0223	CcSEcCtD
Hydroxychloroquine—Hearing impaired—Temozolomide—malignant glioma	0.00677	0.0178	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Temozolomide—malignant glioma	0.00605	0.0159	CcSEcCtD
Hydroxychloroquine—Deafness—Temozolomide—malignant glioma	0.00523	0.0137	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00496	0.013	CcSEcCtD
Hydroxychloroquine—Affect lability—Temozolomide—malignant glioma	0.00461	0.0121	CcSEcCtD
Hydroxychloroquine—Ataxia—Carmustine—malignant glioma	0.00455	0.012	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Carmustine—malignant glioma	0.00447	0.0117	CcSEcCtD
Hydroxychloroquine—Chloroquine—TNF—malignant glioma	0.00444	1	CrCbGaD
Hydroxychloroquine—Mood swings—Temozolomide—malignant glioma	0.00443	0.0116	CcSEcCtD
Hydroxychloroquine—Ataxia—Temozolomide—malignant glioma	0.0044	0.0116	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Carmustine—malignant glioma	0.00427	0.0112	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00421	0.0111	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Temozolomide—malignant glioma	0.00413	0.0108	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Carmustine—malignant glioma	0.00398	0.0104	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Temozolomide—malignant glioma	0.00384	0.0101	CcSEcCtD
Hydroxychloroquine—Depression—Carmustine—malignant glioma	0.00372	0.00978	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00369	0.0097	CcSEcCtD
Hydroxychloroquine—Weight decreased—Temozolomide—malignant glioma	0.00366	0.00962	CcSEcCtD
Hydroxychloroquine—Depression—Temozolomide—malignant glioma	0.0036	0.00945	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00358	0.0094	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Carmustine—malignant glioma	0.00337	0.00885	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Carmustine—malignant glioma	0.00335	0.0088	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Temozolomide—malignant glioma	0.00325	0.00855	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Temozolomide—malignant glioma	0.00324	0.00851	CcSEcCtD
Hydroxychloroquine—Visual impairment—Carmustine—malignant glioma	0.00323	0.00848	CcSEcCtD
Hydroxychloroquine—Eye disorder—Carmustine—malignant glioma	0.00313	0.00823	CcSEcCtD
Hydroxychloroquine—Visual impairment—Temozolomide—malignant glioma	0.00312	0.0082	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Temozolomide—malignant glioma	0.00306	0.00804	CcSEcCtD
Hydroxychloroquine—Eye disorder—Temozolomide—malignant glioma	0.00303	0.00795	CcSEcCtD
Hydroxychloroquine—Tinnitus—Temozolomide—malignant glioma	0.00302	0.00793	CcSEcCtD
Hydroxychloroquine—Alopecia—Carmustine—malignant glioma	0.00296	0.00778	CcSEcCtD
Hydroxychloroquine—Mental disorder—Carmustine—malignant glioma	0.00294	0.00771	CcSEcCtD
Hydroxychloroquine—Malnutrition—Carmustine—malignant glioma	0.00292	0.00766	CcSEcCtD
Hydroxychloroquine—Alopecia—Temozolomide—malignant glioma	0.00286	0.00752	CcSEcCtD
Hydroxychloroquine—Mental disorder—Temozolomide—malignant glioma	0.00284	0.00745	CcSEcCtD
Hydroxychloroquine—Malnutrition—Temozolomide—malignant glioma	0.00282	0.00741	CcSEcCtD
Hydroxychloroquine—Vision blurred—Carmustine—malignant glioma	0.00275	0.00722	CcSEcCtD
Hydroxychloroquine—Anaemia—Carmustine—malignant glioma	0.0027	0.00708	CcSEcCtD
Hydroxychloroquine—Agitation—Carmustine—malignant glioma	0.00268	0.00704	CcSEcCtD
Hydroxychloroquine—Vision blurred—Temozolomide—malignant glioma	0.00266	0.00698	CcSEcCtD
Hydroxychloroquine—Leukopenia—Carmustine—malignant glioma	0.00261	0.00686	CcSEcCtD
Hydroxychloroquine—Anaemia—Temozolomide—malignant glioma	0.0026	0.00684	CcSEcCtD
Hydroxychloroquine—Agitation—Temozolomide—malignant glioma	0.00259	0.00681	CcSEcCtD
Hydroxychloroquine—Angioedema—Temozolomide—malignant glioma	0.00258	0.00677	CcSEcCtD
Hydroxychloroquine—Vertigo—Temozolomide—malignant glioma	0.00253	0.00665	CcSEcCtD
Hydroxychloroquine—Convulsion—Carmustine—malignant glioma	0.00253	0.00664	CcSEcCtD
Hydroxychloroquine—Leukopenia—Temozolomide—malignant glioma	0.00252	0.00663	CcSEcCtD
Hydroxychloroquine—Convulsion—Temozolomide—malignant glioma	0.00244	0.00642	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00238	0.00626	CcSEcCtD
Hydroxychloroquine—Oedema—Carmustine—malignant glioma	0.00238	0.00625	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Carmustine—malignant glioma	0.00233	0.00612	CcSEcCtD
Hydroxychloroquine—Oedema—Temozolomide—malignant glioma	0.0023	0.00604	CcSEcCtD
Hydroxychloroquine—Anorexia—Carmustine—malignant glioma	0.00227	0.00596	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Temozolomide—malignant glioma	0.00226	0.00593	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Temozolomide—malignant glioma	0.00225	0.00592	CcSEcCtD
Hydroxychloroquine—Skin disorder—Temozolomide—malignant glioma	0.00223	0.00587	CcSEcCtD
Hydroxychloroquine—Anorexia—Temozolomide—malignant glioma	0.00219	0.00576	CcSEcCtD
Hydroxychloroquine—Somnolence—Carmustine—malignant glioma	0.00212	0.00556	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Carmustine—malignant glioma	0.00207	0.00544	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00205	0.0054	CcSEcCtD
Hydroxychloroquine—Somnolence—Temozolomide—malignant glioma	0.00204	0.00537	CcSEcCtD
Hydroxychloroquine—Pain—Carmustine—malignant glioma	0.00204	0.00535	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Temozolomide—malignant glioma	0.002	0.00525	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00199	0.00522	CcSEcCtD
Hydroxychloroquine—Fatigue—Temozolomide—malignant glioma	0.00198	0.00521	CcSEcCtD
Hydroxychloroquine—Pain—Temozolomide—malignant glioma	0.00197	0.00517	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Carmustine—malignant glioma	0.00195	0.00511	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Carmustine—malignant glioma	0.00188	0.00494	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Carmustine—malignant glioma	0.00188	0.00494	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00188	0.00494	CcSEcCtD
Hydroxychloroquine—Urticaria—Temozolomide—malignant glioma	0.00183	0.0048	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Temozolomide—malignant glioma	0.00182	0.00478	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Temozolomide—malignant glioma	0.00182	0.00478	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Carmustine—malignant glioma	0.00175	0.00461	CcSEcCtD
Hydroxychloroquine—Asthenia—Carmustine—malignant glioma	0.00171	0.00449	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Temozolomide—malignant glioma	0.00169	0.00445	CcSEcCtD
Hydroxychloroquine—Asthenia—Temozolomide—malignant glioma	0.00165	0.00434	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Carmustine—malignant glioma	0.00163	0.00428	CcSEcCtD
Hydroxychloroquine—Pruritus—Temozolomide—malignant glioma	0.00163	0.00428	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—malignant glioma	0.0016	0.00259	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KRAS—malignant glioma	0.00159	0.00258	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Carmustine—malignant glioma	0.00157	0.00414	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Temozolomide—malignant glioma	0.00157	0.00414	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CFH—malignant glioma	0.00157	0.00255	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—malignant glioma	0.00155	0.00252	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—KRAS—malignant glioma	0.00155	0.00251	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—malignant glioma	0.00153	0.00249	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Temozolomide—malignant glioma	0.00152	0.004	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00152	0.00247	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Carmustine—malignant glioma	0.00151	0.00398	CcSEcCtD
Hydroxychloroquine—Rash—Carmustine—malignant glioma	0.0015	0.00394	CcSEcCtD
Hydroxychloroquine—Dermatitis—Carmustine—malignant glioma	0.0015	0.00394	CcSEcCtD
Hydroxychloroquine—Headache—Carmustine—malignant glioma	0.00149	0.00392	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KRAS—malignant glioma	0.00149	0.00242	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KRAS—malignant glioma	0.00149	0.00242	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—malignant glioma	0.00149	0.00242	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Temozolomide—malignant glioma	0.00146	0.00384	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-C—malignant glioma	0.00146	0.00238	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CA—malignant glioma	0.00146	0.00237	CbGpPWpGaD
Hydroxychloroquine—Rash—Temozolomide—malignant glioma	0.00145	0.00381	CcSEcCtD
Hydroxychloroquine—Dermatitis—Temozolomide—malignant glioma	0.00145	0.00381	CcSEcCtD
Hydroxychloroquine—Headache—Temozolomide—malignant glioma	0.00144	0.00379	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CA—malignant glioma	0.00142	0.00231	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LATS1—malignant glioma	0.00142	0.00231	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL7—malignant glioma	0.00141	0.0023	CbGpPWpGaD
Hydroxychloroquine—Nausea—Carmustine—malignant glioma	0.00141	0.00371	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CA—malignant glioma	0.00141	0.00229	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—malignant glioma	0.00138	0.00225	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CA—malignant glioma	0.00137	0.00223	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CA—malignant glioma	0.00137	0.00223	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—malignant glioma	0.00137	0.00222	CbGpPWpGaD
Hydroxychloroquine—Nausea—Temozolomide—malignant glioma	0.00137	0.00359	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CTSB—malignant glioma	0.00136	0.00221	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFNA2—malignant glioma	0.00135	0.0022	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00132	0.00214	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT1—malignant glioma	0.0013	0.00212	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—DUSP6—malignant glioma	0.00126	0.00206	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CA—malignant glioma	0.00126	0.00205	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—malignant glioma	0.00125	0.00203	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CFH—malignant glioma	0.00124	0.00202	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KRAS—malignant glioma	0.00124	0.00201	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—LGALS3—malignant glioma	0.0012	0.00195	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PARK2—malignant glioma	0.0012	0.00195	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PTK2—malignant glioma	0.00118	0.00191	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CA—malignant glioma	0.00114	0.00185	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PDGFRA—malignant glioma	0.0011	0.00179	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-B—malignant glioma	0.00109	0.00178	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—malignant glioma	0.00108	0.00176	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PML—malignant glioma	0.00108	0.00175	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-C—malignant glioma	0.00108	0.00175	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IFNA2—malignant glioma	0.00107	0.00174	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT1—malignant glioma	0.00103	0.00168	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—malignant glioma	0.00102	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTSB—malignant glioma	0.001	0.00163	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000997	0.00162	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PDGFB—malignant glioma	0.000989	0.00161	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CA—malignant glioma	0.000985	0.0016	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—FGFR1—malignant glioma	0.000984	0.0016	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MDK—malignant glioma	0.000959	0.00156	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—LGALS3—malignant glioma	0.000948	0.00154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PARK2—malignant glioma	0.000948	0.00154	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—DUSP6—malignant glioma	0.000932	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PTK2—malignant glioma	0.000931	0.00151	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—DTX1—malignant glioma	0.000915	0.00149	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FBXW7—malignant glioma	0.000901	0.00147	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—BAD—malignant glioma	0.000882	0.00143	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PDGFRA—malignant glioma	0.000871	0.00142	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-B—malignant glioma	0.000865	0.00141	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD80—malignant glioma	0.000856	0.00139	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PML—malignant glioma	0.000852	0.00139	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-C—malignant glioma	0.000852	0.00139	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EGF—malignant glioma	0.000844	0.00137	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PTPN11—malignant glioma	0.000839	0.00136	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000806	0.00131	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT1—malignant glioma	0.000804	0.00131	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000795	0.00129	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTSB—malignant glioma	0.000791	0.00129	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNA2—malignant glioma	0.000788	0.00128	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PDGFB—malignant glioma	0.000782	0.00127	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT2—malignant glioma	0.000781	0.00127	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—FGFR1—malignant glioma	0.000778	0.00127	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CD—malignant glioma	0.000751	0.00122	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—DUSP6—malignant glioma	0.000737	0.0012	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SUFU—malignant glioma	0.000727	0.00118	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—FGF2—malignant glioma	0.000719	0.00117	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HEY2—malignant glioma	0.000718	0.00117	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FBXW7—malignant glioma	0.000713	0.00116	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GFAP—malignant glioma	0.000701	0.00114	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000699	0.00114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—BAD—malignant glioma	0.000697	0.00113	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.00069	0.00112	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTK2—malignant glioma	0.000686	0.00112	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—BCL2—malignant glioma	0.000683	0.00111	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SPHK1—malignant glioma	0.000678	0.0011	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD80—malignant glioma	0.000676	0.0011	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—MDM2—malignant glioma	0.000673	0.00109	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—RAF1—malignant glioma	0.00067	0.00109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EGF—malignant glioma	0.000667	0.00109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HEY1—malignant glioma	0.000665	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCR4—malignant glioma	0.000665	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PTPN11—malignant glioma	0.000663	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—ERBB2—malignant glioma	0.000663	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CB—malignant glioma	0.000654	0.00106	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HIST1H3B—malignant glioma	0.000646	0.00105	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PDGFRA—malignant glioma	0.000642	0.00104	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-B—malignant glioma	0.000637	0.00104	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNA2—malignant glioma	0.000623	0.00101	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT2—malignant glioma	0.000618	0.001	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CD—malignant glioma	0.000593	0.000965	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-A—malignant glioma	0.00059	0.00096	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JAG2—malignant glioma	0.000589	0.000958	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PDGFB—malignant glioma	0.000576	0.000937	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FGFR1—malignant glioma	0.000573	0.000932	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—FGF2—malignant glioma	0.000568	0.000924	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PTEN—malignant glioma	0.000565	0.00092	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000565	0.000919	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTK2—malignant glioma	0.000542	0.000882	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—BCL2—malignant glioma	0.00054	0.000877	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MDM2—malignant glioma	0.000532	0.000865	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—RAF1—malignant glioma	0.00053	0.000862	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.00053	0.000862	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ERBB2—malignant glioma	0.000524	0.000852	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CB—malignant glioma	0.000517	0.000841	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BAD—malignant glioma	0.000514	0.000835	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PDGFRA—malignant glioma	0.000507	0.000825	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-B—malignant glioma	0.000504	0.000819	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—H3F3A—malignant glioma	0.000499	0.000811	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD80—malignant glioma	0.000498	0.00081	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCR3—malignant glioma	0.000494	0.000803	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGF—malignant glioma	0.000492	0.0008	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTPN11—malignant glioma	0.000489	0.000795	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NTRK2—malignant glioma	0.00048	0.000781	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—YWHAE—malignant glioma	0.00048	0.000781	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FLT1—malignant glioma	0.000478	0.000778	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—DUSP6—malignant glioma	0.000476	0.000774	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JAG1—malignant glioma	0.00047	0.000765	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH3—malignant glioma	0.000468	0.000761	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-A—malignant glioma	0.000467	0.000759	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FBXW7—malignant glioma	0.000461	0.000749	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EGFR—malignant glioma	0.00046	0.000747	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PDGFB—malignant glioma	0.000456	0.000741	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT2—malignant glioma	0.000455	0.00074	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FGFR1—malignant glioma	0.000453	0.000737	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BDKRB2—malignant glioma	0.000452	0.000735	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PTEN—malignant glioma	0.000447	0.000727	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CD—malignant glioma	0.000437	0.000711	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—malignant glioma	0.000434	0.000706	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH2—malignant glioma	0.00042	0.000683	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FGF2—malignant glioma	0.000419	0.000681	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KNG1—malignant glioma	0.000411	0.000668	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BAD—malignant glioma	0.000406	0.00066	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—malignant glioma	0.000399	0.000649	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BCL2—malignant glioma	0.000398	0.000646	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000396	0.000644	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNG—malignant glioma	0.000394	0.000641	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD80—malignant glioma	0.000394	0.000641	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000392	0.000637	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MDM2—malignant glioma	0.000392	0.000637	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NTRK1—malignant glioma	0.000392	0.000637	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RAF1—malignant glioma	0.00039	0.000635	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGF—malignant glioma	0.000389	0.000632	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000387	0.000629	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTPN11—malignant glioma	0.000386	0.000628	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERBB2—malignant glioma	0.000386	0.000628	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CB—malignant glioma	0.000381	0.00062	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP3—malignant glioma	0.000364	0.000592	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—malignant glioma	0.000363	0.000591	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN2B—malignant glioma	0.000361	0.000587	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT2—malignant glioma	0.00036	0.000585	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—malignant glioma	0.000351	0.000571	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTK2—malignant glioma	0.000351	0.00057	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—malignant glioma	0.00035	0.000569	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CD—malignant glioma	0.000346	0.000562	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HES1—malignant glioma	0.000344	0.00056	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—malignant glioma	0.000343	0.000558	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NCOR1—malignant glioma	0.000342	0.000557	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FGF2—malignant glioma	0.000331	0.000538	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTEN—malignant glioma	0.000329	0.000536	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFRA—malignant glioma	0.000328	0.000533	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—malignant glioma	0.000326	0.00053	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SPP1—malignant glioma	0.000318	0.000518	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—malignant glioma	0.000315	0.000513	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2—malignant glioma	0.000314	0.000511	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNG—malignant glioma	0.000311	0.000506	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MDM2—malignant glioma	0.00031	0.000504	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RAF1—malignant glioma	0.000309	0.000502	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ERBB2—malignant glioma	0.000305	0.000496	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TERT—malignant glioma	0.000302	0.000491	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CB—malignant glioma	0.000301	0.00049	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—STAT3—malignant glioma	0.000295	0.000479	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFB—malignant glioma	0.000295	0.000479	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGFR1—malignant glioma	0.000293	0.000476	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HIF1A—malignant glioma	0.000289	0.000469	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CAV1—malignant glioma	0.000279	0.000454	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—malignant glioma	0.000278	0.000452	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2—malignant glioma	0.000277	0.00045	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KDR—malignant glioma	0.000276	0.000449	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—malignant glioma	0.000268	0.000435	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—F2—malignant glioma	0.000266	0.000432	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FN1—malignant glioma	0.000266	0.000432	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BAD—malignant glioma	0.000262	0.000427	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTEN—malignant glioma	0.00026	0.000423	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH1—malignant glioma	0.00026	0.000423	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—malignant glioma	0.000258	0.000419	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CD80—malignant glioma	0.000255	0.000414	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CG—malignant glioma	0.000254	0.000413	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APC—malignant glioma	0.000254	0.000413	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—malignant glioma	0.000253	0.000411	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGF—malignant glioma	0.000251	0.000409	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTPN11—malignant glioma	0.00025	0.000406	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BRAF—malignant glioma	0.000239	0.000389	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—malignant glioma	0.000233	0.000379	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT2—malignant glioma	0.000233	0.000378	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—malignant glioma	0.000232	0.000378	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—COX8A—malignant glioma	0.000228	0.00037	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CD—malignant glioma	0.000223	0.000363	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGF2—malignant glioma	0.000214	0.000348	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—malignant glioma	0.000212	0.000344	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MDM2—malignant glioma	0.0002	0.000326	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—malignant glioma	0.0002	0.000325	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RAF1—malignant glioma	0.0002	0.000324	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB2—malignant glioma	0.000197	0.000321	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CB—malignant glioma	0.000195	0.000317	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ASMT—malignant glioma	0.000194	0.000315	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—malignant glioma	0.00019	0.000309	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—malignant glioma	0.000187	0.000304	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—malignant glioma	0.000184	0.000299	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BCAN—malignant glioma	0.000182	0.000296	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—malignant glioma	0.000179	0.000291	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—malignant glioma	0.000179	0.000291	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—malignant glioma	0.000169	0.000275	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTEN—malignant glioma	0.000168	0.000274	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—malignant glioma	0.000152	0.000247	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—malignant glioma	0.000151	0.000245	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—malignant glioma	0.00015	0.000244	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—IDH2—malignant glioma	0.000147	0.000238	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—malignant glioma	0.00014	0.000227	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000138	0.000224	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—malignant glioma	0.000137	0.000222	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—malignant glioma	0.000129	0.00021	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—IDH1—malignant glioma	0.000126	0.000205	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000122	0.000198	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.00012	0.000194	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—malignant glioma	0.000119	0.000193	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—malignant glioma	0.000115	0.000187	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—malignant glioma	9.7e-05	0.000158	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTT1—malignant glioma	9.67e-05	0.000157	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS1—malignant glioma	9.06e-05	0.000147	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BCHE—malignant glioma	8.42e-05	0.000137	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.32e-05	0.000135	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTP1—malignant glioma	6.7e-05	0.000109	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CAT—malignant glioma	6.52e-05	0.000106	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOR1—malignant glioma	6.16e-05	0.0001	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CAV1—malignant glioma	5.02e-05	8.16e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.57e-05	7.44e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARG—malignant glioma	4.41e-05	7.18e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.02e-05	6.54e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.5e-05	5.7e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.47e-05	5.65e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTEN—malignant glioma	3.03e-05	4.92e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.14e-05	3.47e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—malignant glioma	1.75e-05	2.84e-05	CbGpPWpGaD
